![]() |
![]() scientific design, conduct, analysis & reporting of clinical trials |
||||||||||||||||||||||||||||||||||
|
Lagakos' Symposium
"Impact of Biostatistical Science - Advances in Research: AIDS, Cancer, Environment"
Sharon-Lise Normand
Sharon-Lise T. Normand, PhD, is Professor of Health Care Policy (Biostatistics) in the Department of Health Care Policy, Harvard Medical School and in the Department of Biostatistics, Harvard School of Public Health. Her research focuses on the development of methods for health services research, primarily using Bayesian approaches. She is director of Mass-DAC, a data-coordinating center responsible for collecting, analyzing, and reporting on quality of care for adults discharged following a cardiac procedure from all hospitals in Massachusetts. She is the senior statistician in a 3,000-patient trial in Massachusetts to compare the effectiveness of elective angioplasty at hospitals without surgery on-site with that at hospitals with surgery on-site. Dr. Normand is leading a study to expand inferences using observational data by extending methods for causal inference in the experimental and observational settings with data on different measurement scales. This work is illustrated in understanding policy changes in the delivery of mental health care where multiple outcomes are reported. With colleagues from FDA’s Center for Devices and Radiographic Health, she is evaluating the relationship of hip replacements, patient, surgeon, and regional characteristics on long-term device and clinical outcomes. The goal is to demonstrate the feasibility of hip device monitoring by quantifying the prognostic ability of models that pool multiple data sources. Dr. Normand earned her BSc and MSc Degrees in Btatistics from the University of Western Ontario and PhD in Biostatistics from the University of Toronto. She is a fellow of the American Statistical Association; the American College of Cardiology the American Heart Association; and an Associate of the Society of Thoracic Surgeons. She is the 2010 ENAR President; and is a member of two Institute of Medicine Committees: Aerospace Medicine & the Medicine of Extreme Environments, and National Surveillance System for Cardiovascular & Select Chronic Conditions.
Frontier Science Foundation-Hellas 2007-2011 |
||||||||||||||||||||||||||||||||||